<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">606162666</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20210128100640.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">210128e20150201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s11062-015-9500-7</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s11062-015-9500-7</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Suppression of GABAergic Synaptic Transmission by Azidin: Probable Mechanism of a Seizure-Inducing Side Effect</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[S. Ivanova, L. Nikolayenko, M. Storozhuk]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Azidin (Berenil, Intervet) is a protisticide drug based on diminazene aceturate. It is widely used in veterinary medicine for the treatment and prophylactics of piroplasmosis, babesioses, and teileriosis. Azidin is not used in clinical practice because of the probability of serious side effects, in particular initiation of seizure activity. We examined the effect of Azidin on evoked GABAergic postsynaptic currents (PSTs) in cultured hippocampal neurons using a patch clamp technique. As was found, Azidin in a concentration equivalent to 40 μM diminazene aceturate provides a more than twofold drop in the amplitude of evoked GABAergic PSTs; the effect develops in 3 to 4 min after application. The diminazene concentration in blood serum after its injection into animals can reach 45 μM; this is why the seizure side effect of Azidin can probably be explained mostly by suppression of GABAergic transmission. A combination of Azidin with positive modulators of GABA receptors can be considered an approach allowing one to minimize its side effect.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media New York, 2015</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">diminazene aceturate (Azidin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Berenil)</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">side effects</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">seizure activity</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">GABAergic synaptic transmission</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Ivanova</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Nikolayenko</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Storozhuk</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Neurophysiology</subfield>
   <subfield code="d">Springer US; http://www.springer-ny.com</subfield>
   <subfield code="g">47/1(2015-02-01), 77-79</subfield>
   <subfield code="x">0090-2977</subfield>
   <subfield code="q">47:1&lt;77</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">47</subfield>
   <subfield code="o">11062</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s11062-015-9500-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s11062-015-9500-7</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Ivanova</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Nikolayenko</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Storozhuk</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Bogomolets Institute of Physiology, NAS of Ukraine, Kyiv, Ukraine</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Neurophysiology</subfield>
   <subfield code="d">Springer US; http://www.springer-ny.com</subfield>
   <subfield code="g">47/1(2015-02-01), 77-79</subfield>
   <subfield code="x">0090-2977</subfield>
   <subfield code="q">47:1&lt;77</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">47</subfield>
   <subfield code="o">11062</subfield>
  </datafield>
 </record>
</collection>
